New Delhi, Sep 30 (PTI) A new study has described how molecular changes triggered by a viral infection may pave way for one to develop neurodegenerative diseases such as Parkinson's disease ...

This post is the first in a five-part series summarizing APDA’s recent “Ask the Expert” event on Smart Patients. During the ...

Some people live with essential tremor for years and organically find ways to adapt. Others may begin avoiding activities.

The causes of Parkinson's disease (PD) have not yet been fully elucidated, but in addition to aging and genetic factors, ...

Freezing of Gait (FOG) is a disabling feature of Parkinson’s disease (PD). However, the neural mechanisms underlying voluntary stopping impairments remain unclear. This study used a validated Virtual ...

A new study by CSIR-CCMB researchers has elucidated the molecular mechanisms by which viral infections, particularly RNA viruses like Influenza and COVID-19, can accelerate the formation of amyloid ...

Poster Title: Long-Term Open-Label Data on the GCase Modulator GT-02287 ( Rexaceract) in People with Parkinson’s Disease Location : Hall D, 3 rd Floor, E-Poster Station 12 The International Parkinson ...

Hyderabad’s CCMB has identified how viral RNA structures may accelerate α-synuclein amyloid formation linked to Parkinson’s ...

Italian students have developed a smart sock that turns the rhythm of a person's favourite music into gentle vibrations ...

Persistent symptoms can harm the lungs and other organs, including the brain.

Today's FDA approval of tavapadon makes it the first selective D1/D5 receptor agonist for the treatment of adults with Parkinson's disease.

The study, published in ‘Cell Reports’, examined how RNA viruses interact with a protein named alpha-synuclein, that forms ...